<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">445883405</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180317145551.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170323e20111001xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/s10157-011-0472-7</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/s10157-011-0472-7</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Nephrologist care for 12months or more increases hemodialysis initiation with permanent vascular access</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Daijo Inaguma, Ryoichi Ando, Masato Ikeda, Nobuhiko Joki, Fumihiko Koiwa, Yasuhiro Komatsu, Toshihumi Sakaguchi, Toshio Shinoda, Toshihiko Yamaka, Takashi Shigematsu]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Background: The objective of this study was to evaluate the effect of early referral (ER) to nephrologists on the type of vascular access (VA) available for use at the time of initiation of maintenance hemodialysis (HD). In patients who have been followed by nephrologists for less than 3months, management before the initiation of HD is often insufficient and urgent initiation of HD is often necessary; therefore, patients in this study were limited to those who had been followed for at least 3months by nephrologists. Methods: Nine hundred and forty patients at 9 institutions affiliated to our study group were enrolled in this retrospective observational study. We defined patients followed up by nephrologists for at least 12months as the early referral (ER) group and those followed for between 3 and 12months as the late referral (LR) group. The type of VA available for use at the initiation of maintenance HD was compared between the groups. Results: Early referral was found to be significantly associated with the availability of a permanent VA, which included an arteriovenous fistula or arteriovenous graft, at the time of initiation of HD (odds ratio [OR] 1.705; P=0.001). Multivariate analysis also revealed ER to be significantly associated with the availability of a permanent VA (OR 1.509; P=0.023). Conclusion: Early referral was shown to be advantageous for increasing the likelihood of availability of a permanent VA, even after patients who had been followed up for less than 3months by nephrologists were excluded.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Japanese Society of Nephrology, 2011</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Early referral</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Hemodialysis</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Vascular access</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Inaguma</subfield>
   <subfield code="D">Daijo</subfield>
   <subfield code="u">Department of Nephrology, Nagoya Daini Red Cross Hospital, Myoken-cho 2-9, Showa-Ku, 466-8650, Nagoya, Aichi, Japan</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Ando</subfield>
   <subfield code="D">Ryoichi</subfield>
   <subfield code="u">Study Group for Assessing Initiation of Renal Replacement Therapy, Tokyo, Japan</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Ikeda</subfield>
   <subfield code="D">Masato</subfield>
   <subfield code="u">Study Group for Assessing Initiation of Renal Replacement Therapy, Tokyo, Japan</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Joki</subfield>
   <subfield code="D">Nobuhiko</subfield>
   <subfield code="u">Study Group for Assessing Initiation of Renal Replacement Therapy, Tokyo, Japan</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Koiwa</subfield>
   <subfield code="D">Fumihiko</subfield>
   <subfield code="u">Study Group for Assessing Initiation of Renal Replacement Therapy, Tokyo, Japan</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Komatsu</subfield>
   <subfield code="D">Yasuhiro</subfield>
   <subfield code="u">Study Group for Assessing Initiation of Renal Replacement Therapy, Tokyo, Japan</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Sakaguchi</subfield>
   <subfield code="D">Toshihumi</subfield>
   <subfield code="u">Study Group for Assessing Initiation of Renal Replacement Therapy, Tokyo, Japan</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Shinoda</subfield>
   <subfield code="D">Toshio</subfield>
   <subfield code="u">Study Group for Assessing Initiation of Renal Replacement Therapy, Tokyo, Japan</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Yamaka</subfield>
   <subfield code="D">Toshihiko</subfield>
   <subfield code="u">Study Group for Assessing Initiation of Renal Replacement Therapy, Tokyo, Japan</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Shigematsu</subfield>
   <subfield code="D">Takashi</subfield>
   <subfield code="u">Study Group for Assessing Initiation of Renal Replacement Therapy, Tokyo, Japan</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Clinical and Experimental Nephrology</subfield>
   <subfield code="d">Springer Japan</subfield>
   <subfield code="g">15/5(2011-10-01), 738-744</subfield>
   <subfield code="x">1342-1751</subfield>
   <subfield code="q">15:5&lt;738</subfield>
   <subfield code="1">2011</subfield>
   <subfield code="2">15</subfield>
   <subfield code="o">10157</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/s10157-011-0472-7</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/s10157-011-0472-7</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Inaguma</subfield>
   <subfield code="D">Daijo</subfield>
   <subfield code="u">Department of Nephrology, Nagoya Daini Red Cross Hospital, Myoken-cho 2-9, Showa-Ku, 466-8650, Nagoya, Aichi, Japan</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Ando</subfield>
   <subfield code="D">Ryoichi</subfield>
   <subfield code="u">Study Group for Assessing Initiation of Renal Replacement Therapy, Tokyo, Japan</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Ikeda</subfield>
   <subfield code="D">Masato</subfield>
   <subfield code="u">Study Group for Assessing Initiation of Renal Replacement Therapy, Tokyo, Japan</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Joki</subfield>
   <subfield code="D">Nobuhiko</subfield>
   <subfield code="u">Study Group for Assessing Initiation of Renal Replacement Therapy, Tokyo, Japan</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Koiwa</subfield>
   <subfield code="D">Fumihiko</subfield>
   <subfield code="u">Study Group for Assessing Initiation of Renal Replacement Therapy, Tokyo, Japan</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Komatsu</subfield>
   <subfield code="D">Yasuhiro</subfield>
   <subfield code="u">Study Group for Assessing Initiation of Renal Replacement Therapy, Tokyo, Japan</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Sakaguchi</subfield>
   <subfield code="D">Toshihumi</subfield>
   <subfield code="u">Study Group for Assessing Initiation of Renal Replacement Therapy, Tokyo, Japan</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Shinoda</subfield>
   <subfield code="D">Toshio</subfield>
   <subfield code="u">Study Group for Assessing Initiation of Renal Replacement Therapy, Tokyo, Japan</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Yamaka</subfield>
   <subfield code="D">Toshihiko</subfield>
   <subfield code="u">Study Group for Assessing Initiation of Renal Replacement Therapy, Tokyo, Japan</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Shigematsu</subfield>
   <subfield code="D">Takashi</subfield>
   <subfield code="u">Study Group for Assessing Initiation of Renal Replacement Therapy, Tokyo, Japan</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Clinical and Experimental Nephrology</subfield>
   <subfield code="d">Springer Japan</subfield>
   <subfield code="g">15/5(2011-10-01), 738-744</subfield>
   <subfield code="x">1342-1751</subfield>
   <subfield code="q">15:5&lt;738</subfield>
   <subfield code="1">2011</subfield>
   <subfield code="2">15</subfield>
   <subfield code="o">10157</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
